Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Presyncope, SARS-CoV-2 test, Vision blurred, Vomiting
Clinical narrative: About 24 hours after my second dose of Covid vaccine, I felt strong nausea and was very close to fainting: my head felt heavy, sudden weakness, losing control of the environment, my vision blackened,; About 24 hours after my second dose of Covid vaccine, I felt strong nausea and was very close to fainting: my head felt heavy, sudden weakness, losing control of the environment, my vision blackened,; About 24 hours after my second dose of Covid vaccine, I felt strong nausea and was very close to fainting: my head felt heavy, sudden weakness, losing control of the environment, my vision blackened,; About 24 hours after my second dose of Covid vaccine, I felt strong nausea and was very close to fainting: my head felt heavy, sudden weakness, losing control of the environment, my vision blackened,; About 24 hours after my second dose of Covid vaccine, I felt strong nausea and was very close to fainting: my head felt heavy, sudden weakness, losing control of the environment, my vision blackened,; collapsed in bed before hitting the floor; Blood pressure Drop; Few minutes later urge to vomit (spasm); This is a spontaneous report from a contactable consumer (patient). A 50-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0186; Expiration Date: 31Aug2021), via intramuscular route of administration in right arm on 23May2021 at 09:15 (at the age of 50 years old, not pregnant at the time of vaccination) as dose 2, single for covid-19 immunisation. Medical history included hypothyroidism and family medical history included hypertension, stroke, heart attack, diabetes mellitus. The patient had known allergies penicillin, cantaloupe. Concomitant medications the patient received within 2 weeks of vaccination included levothyroxine sodium (SYNTHROID), 75mg for thyroid disorder; ascorbic acid, betacarotene, biotin, calcium, chlorine, chromium, copper, cyanocobalamin, dl-alpha tocopheryl acetate, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon, thiamine, vanadium, vitamin d nos, xantofyl, zinc (multivitamin +50); biotin; ascorbic acid (VITAMIIN C); colecalciferol (VITAMIN D 3). Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN5318), via intramuscular route of administration in left arm on 02May2021 at 10:00 AM (at the age of 50 years old) for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. On 24May2021 at 09:00 AM, about 24 hours after second dose of Covid vaccine, she felt strong nausea and was very close to fainting: her head felt heavy, sudden weakness, losing control of the environment, her vision blackened, she collapsed in bed before hitting the floor, but remained conscious. A minute or so later she had the urge to throw up but nothing came out, then she had a normal bowl movement, took 1 tylenol 500 mg, and went to bed to rest. Strong nausea followed by vison darkness, loss of environment control, her head felt heavy, blood pressure drop on 24May2021, almost collapsed on the floor. Few minutes later urge to vomit (spasm). The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 23Jun2020 Other. no relevant tests were performed. Autopsy not performed. The patient did not received treatment due to the events. The outcome of blood pressure drop, few minutes later urge to vomit (spasm) was unknown, presyncope was recovered on an unspecified date in 2021, while with other events was recovering.  Follow-Up (29Jul2021): Follow-up attempts are completed. No further information is expected.